QIAGEN N.V. Operating Income 2011-2026 | QGEN

Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.

Formula

Operating profit = Revenue – Operating expenses

Features of the metric

Evaluates business efficiency
Shows how well the company controls its production and administrative costs.
Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies.
Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.

If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.

Annual Operating Income QIAGEN N.V.

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
97.7 M	410 M	531 M	630 M	386 M	-26.1 M	267 M	153 M	98.8 M	179 M	162 M	63.3 M	170 M	99.6 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
630 M	-26.1 M	230 M

Operating Income of other stocks in the Diagnostics research industry

Issuer	Operating Income	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-46 M	-	-6.23 %	$ 30.6 M	Germany
CareDx, Inc CDNA	-30.8 M	$ 17.56	-	$ 936 M	USA
Quest Diagnostics Incorporated DGX	1.56 B	$ 195.6	-	$ 21.7 B	USA
DexCom DXCM	912 M	$ 65.94	-	$ 25.7 B	USA
Exact Sciences Corporation EXAS	-206 M	$ 104.91	-	$ 19.8 B	USA
Fulgent Genetics FLGT	-73.9 M	$ 16.33	-	$ 494 M	USA
Biomerica BMRA	-5.14 M	$ 2.13	-	$ 4.89 M	USA
Akumin AKU	-28.1 M	-	-17.87 %	$ 25.9 M	Canada
Enzo Biochem ENZ	-12.4 M	-	-8.98 %	$ 14.8 K	USA
Lantheus Holdings LNTH	311 M	$ 75.73	-	$ 5.11 B	USA
Check-Cap Ltd. CHEK	-25.9 M	-	-	$ 9.42 M	Israel
Medpace Holdings MEDP	535 M	$ 456.93	-	$ 13.2 B	USA
Myriad Genetics MYGN	-387 M	$ 4.66	-	$ 432 M	USA
Castle Biosciences CSTL	8.67 M	$ 25.75	-	$ 715 M	USA
National Research Corporation NRC	22.6 M	$ 17.51	-	$ 392 M	USA
DermTech DMTK	-104 M	-	-11.32 %	$ 2.94 M	USA
Aspira Women's Health AWH	-32.8 M	-	-6.19 %	$ 10.5 M	USA
Pacific Biosciences of California PACB	-554 M	$ 1.39	-	$ 417 M	USA
Co-Diagnostics CODX	-42.7 M	$ 4.4	101.83 %	$ 129 M	USA
Accelerate Diagnostics AXDX	-14 M	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	609 M	-	-	$ 399 M	China
Precipio PRPO	-7.62 M	$ 26.93	-3.41 %	$ 35 M	USA
Personalis PSNL	-68.3 M	$ 7.61	-	$ 451 M	USA
Genetron Holdings Limited GTH	-518 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	25.2 M	$ 158.0	-	$ 7.83 B	USA
IQVIA Holdings IQV	2.18 B	$ 166.96	-	$ 28.7 B	USA
Senseonics Holdings SENS	-68.3 M	$ 6.62	-	$ 276 M	USA
Sotera Health Company SHC	248 M	$ 13.88	-	$ 3.94 B	USA
Neuronetics STIM	-31.4 M	$ 1.6	-	$ 106 M	USA
Biocept BIOC	-32 M	-	-13.05 %	$ 7.29 M	USA
Invitae Corporation NVTA	-94.9 M	-	-	$ 21.2 M	USA
BioNano Genomics BNGO	-33.3 M	$ 1.46	-	$ 7.95 M	USA
Interpace Biosciences IDXG	8.11 M	$ 1.71	0.73 %	$ 7.5 M	USA
IDEXX Laboratories IDXX	1.36 B	$ 578.51	-	$ 46.5 B	USA
Trinity Biotech plc TRIB	6.62 M	$ 0.6	-	$ 61.9 M	Irlanda
Agilent Technologies A	1.35 B	$ 112.02	-	$ 34.1 B	USA
Illumina ILMN	-833 M	$ 123.79	-	$ 19.7 B	USA
ICON Public Limited Company ICLR	1.1 B	$ 100.35	-	$ 8.28 B	Irlanda
DarioHealth Corp. DRIO	-36.7 M	$ 7.5	-6.13 %	$ 29.9 M	Israel
Twist Bioscience Corporation TWST	-136 M	$ 44.5	-	$ 2.66 B	USA
Guardant Health GH	-437 M	$ 84.9	-0.07 %	$ 10.6 B	USA
Celcuity CELC	-113 M	$ 106.75	-	$ 4.21 B	USA
Chembio Diagnostics CEMI	-23.6 M	-	0.22 %	$ 16.8 M	USA
Laboratory Corporation of America Holdings LH	1.38 B	$ 264.42	-	$ 22 B	USA